Aptevo Therapeutics Inc.(APVO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

APVO Aptevo Therapeutics Inc.

盘后交易 12-05 17:11:32 EST

1.35

-0.04

-2.88%

盘后1.38

+0.03+2.22%

17:03 EST

最高1.39	最低1.34	成交量48.45万
今开1.39	昨收1.39	日振幅3.60%
总市值2,275万	流通市值1,824万	总股本1,685万
成交额66.24万	换手率3.59%	流通股本1,351万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"APVO","market":"US","secType":"STK","nameCN":"Aptevo Therapeutics Inc.","latestPrice":1.35,"timestamp":1764968400000,"preClose":1.39,"halted":0,"volume":484499,"hourTrading":{"tag":"盘后","latestPrice":1.38,"preClose":1.35,"latestTime":"17:03 EST","volume":3306,"amount":4548.6936624,"timestamp":1764972213973},"delay":0,"floatShares":13509000,"shares":16850494,"eps":-110.77861,"marketStatus":"盘后交易","change":-0.04,"latestTime":"12-05 17:11:32 EST","open":1.39,"high":1.39,"low":1.34,"amount":662355.9666054,"amplitude":0.035971,"askPrice":1.4,"askSize":2,"bidPrice":1.34,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-110.77861,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1764982800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.39,"preHourTrading":{"tag":"盘前","latestPrice":1.38,"preClose":1.39,"latestTime":"09:29 EST","volume":24073,"amount":34018.338672499995,"timestamp":1764944970037},"postHourTrading":{"tag":"盘后","latestPrice":1.38,"preClose":1.35,"latestTime":"17:03 EST","volume":3306,"amount":4548.6936624,"timestamp":1764972213973},"volumeRatio":1.075318},"requestUrl":"/m/hq/s/APVO","defaultTab":"news","newsList":[{"id":"2552397171","title":"Aptevo Therapeutics Inc.7月16日成交额为59.22万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552397171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552397171?lang=zh_cn&edition=full","pubTime":"2025-07-17 09:17","pubTimestamp":1752715042,"startTime":"0","endTime":"0","summary":"美东时间2025年7月16日，Aptevo Therapeutics Inc.成交额为59.22万美元，成交额较昨日增加29.77%，当日成交量为19.96万股。Aptevo Therapeutics Inc.于2025年7月16日涨3.77%，报3.03美元，该股过去5个交易日跌0.33%，年初至今跌96.48%，过去60日跌82.42%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-16|59.22万|29.77%|19.96万|#|2025-07-15|45.64万|-21.37%|15.64万|#|2025-07-14|58.04万|50.85%|19.66万|#|2025-07-11|38.48万|-5.94%|12.94万|#|2025-07-10|40.91万|-40.92%|13.59万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717091733a44fbf00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717091733a44fbf00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","APVO","BK4139","BK4539"],"gpt_icon":0},{"id":"2546525088","title":"Aptevo Therapeutics Inc.6月24日成交额为433.61万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546525088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546525088?lang=zh_cn&edition=full","pubTime":"2025-06-25 09:16","pubTimestamp":1750814213,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日，Aptevo Therapeutics Inc.成交额为433.61万美元，成交额较昨日减少5.77%，当日成交量为119.35万股。Aptevo Therapeutics Inc.于2025年6月24日涨6.46%，报3.46美元，该股过去5个交易日跌5.46%，年初至今跌95.99%，过去60日跌86.16%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-24|433.61万|-5.77%|119.35万|#|2025-06-23|460.17万|-65.75%|128.68万|#|2025-06-20|1343.48万|-98.62%|322.58万|#|2025-06-18|9.70亿|107168.47%|1.24亿|#|2025-06-17|90.45万|60.64%|26.88万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625091706a71c1047&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625091706a71c1047&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4539","APVO","LENZ"],"gpt_icon":1},{"id":"2544909909","title":"美股异动 | Mipletamig疗法在白血病患者中达到85%缓解率 Aptevo Therapeutics(APVO.US)飙升超130%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544909909","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544909909?lang=zh_cn&edition=full","pubTime":"2025-06-18 23:41","pubTimestamp":1750261300,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周三，Aptevo Therapeutics(APVO.US)飙升超130%，报6.52美元。消息面上，该公司表示，其mipletamig组合疗法在前线急性髓性白血病患者中达到85%的缓解率。根据Aptevo所述的1b/2期Rainer试验结果，mipletamig的治疗方法在不适合化疗的患者中显示出强大的疗效和安全性。该试验的第3组正在以测试的最高剂量水平接近完全入组，公司的乐观态度使其对mipletamig的潜力充满信心。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1306994.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","LENZ","APVO","BK4007","BK4539"],"gpt_icon":0},{"id":"2544987530","title":"Aptevo Therapeutics Inc.6月16日成交额为56.31万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544987530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544987530?lang=zh_cn&edition=full","pubTime":"2025-06-17 09:17","pubTimestamp":1750123022,"startTime":"0","endTime":"0","summary":"美东时间2025年6月16日，Aptevo Therapeutics Inc.成交额为56.31万美元，成交额较昨日减少15.62%，当日成交量为14.85万股。Aptevo Therapeutics Inc.于2025年6月16日跌16.63%，报3.66美元，该股过去5个交易日跌21.79%，年初至今跌95.75%，过去60日跌92.59%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-16|56.31万|-15.62%|14.85万|#|2025-06-13|66.73万|481.09%|14.81万|#|2025-06-12|11.48万|-68.74%|2.48万|#|2025-06-11|36.74万|214.73%|7.76万|#|2025-06-10|11.67万|-69.70%|2.51万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617091713a4ad2b52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617091713a4ad2b52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APVO","BK4139","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2543651367","title":"Aptevo Therapeutics Inc.6月13日成交额为66.73万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543651367","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543651367?lang=zh_cn&edition=full","pubTime":"2025-06-14 09:17","pubTimestamp":1749863821,"startTime":"0","endTime":"0","summary":"美东时间2025年6月13日，Aptevo Therapeutics Inc.成交额为66.73万美元，成交额较昨日增加481.09%，当日成交量为14.81万股。Aptevo Therapeutics Inc.于2025年6月13日跌8.16%，报4.39美元，该股过去5个交易日跌11.31%，年初至今跌94.91%，过去60日跌91.65%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-13|66.73万|481.09%|14.81万|#|2025-06-12|11.48万|-68.74%|2.48万|#|2025-06-11|36.74万|214.73%|7.76万|#|2025-06-10|11.67万|-69.70%|2.51万|#|2025-06-09|38.53万|29.56%|7.97万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614091708a4a87407&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614091708a4a87407&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APVO","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2538419896","title":"Aptevo Therapeutics Inc.5月27日成交额为84.86万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538419896","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538419896?lang=zh_cn&edition=full","pubTime":"2025-05-28 09:16","pubTimestamp":1748395009,"startTime":"0","endTime":"0","summary":"美东时间2025年5月27日，Aptevo Therapeutics Inc.成交额为84.86万美元，成交额较昨日增加46.26%，当日成交量为17.47万股。Aptevo Therapeutics Inc.于2025年5月27日跌10.68%，报4.92美元，该股过去5个交易日跌20.65%，年初至今跌94.29%，过去60日跌93.56%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-27|84.86万|46.26%|17.47万|#|2025-05-23|58.02万|-64.76%|215.09万|#|2025-05-22|164.62万|-97.38%|528.60万|#|2025-05-21|6278.56万|47663.84%|1.19亿|#|2025-05-20|13.14万|-36.93%|41.73万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528091721a6ef9026&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528091721a6ef9026&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APVO","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2537232165","title":"Aptevo Therapeutics Inc.5月23日成交额为58.02万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537232165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537232165?lang=zh_cn&edition=full","pubTime":"2025-05-24 09:16","pubTimestamp":1748049399,"startTime":"0","endTime":"0","summary":"美东时间2025年5月23日，Aptevo Therapeutics Inc.成交额为58.02万美元，成交额较昨日减少64.76%，当日成交量为215.09万股。Aptevo Therapeutics Inc.于2025年5月23日跌8.2%，报0.275美元，该股过去5个交易日跌13.94%，年初至今跌93.61%，过去60日跌92.33%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-23|58.02万|-64.76%|215.09万|#|2025-05-22|164.62万|-97.38%|528.60万|#|2025-05-21|6278.56万|47663.84%|1.19亿|#|2025-05-20|13.14万|-36.93%|41.73万|#|2025-05-19|20.84万|18.20%|68.69万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524091649a48a4b85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524091649a48a4b85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APVO","BK4007","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2537134790","title":"Aptevo Therapeutics Inc.盘中异动 早盘大幅下挫9.63%报0.271美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537134790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537134790?lang=zh_cn&edition=full","pubTime":"2025-05-23 21:32","pubTimestamp":1748007151,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日21时32分，Aptevo Therapeutics Inc.股票出现波动，股价急速下跌9.63%。截至发稿，该股报0.271美元/股，成交量48.6873万股，换手率6.00%，振幅5.57%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.82%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523213231a6ea5e43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523213231a6ea5e43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","APVO","BK4007","BK4139"],"gpt_icon":0},{"id":"2537944579","title":"Aptevo Therapeutics Inc.盘中异动 急速下跌21.05%报0.300美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537944579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537944579?lang=zh_cn&edition=full","pubTime":"2025-05-22 21:31","pubTimestamp":1747920696,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日21时31分，Aptevo Therapeutics Inc.股票出现波动，股价快速下跌21.05%。截至发稿，该股报0.300美元/股，成交量190.037万股，换手率23.43%，振幅6.05%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522213136a6e8f15b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522213136a6e8f15b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4539","APVO","LENZ"],"gpt_icon":0},{"id":"2537496570","title":"Aptevo Therapeutics Inc.5月21日成交额为6278.56万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537496570","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537496570?lang=zh_cn&edition=full","pubTime":"2025-05-22 09:16","pubTimestamp":1747876590,"startTime":"0","endTime":"0","summary":"美东时间2025年5月21日，Aptevo Therapeutics Inc.成交额为6278.56万美元，成交额较昨日增加47663.84%，当日成交量为1.19亿股。Aptevo Therapeutics Inc.于2025年5月21日涨22.62%，报0.38美元，该股过去5个交易日涨15.15%，年初至今跌91.18%，过去60日跌87.62%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-21|6278.56万|47663.84%|1.19亿|#|2025-05-20|13.14万|-36.93%|41.73万|#|2025-05-19|20.84万|18.20%|68.69万|#|2025-05-16|17.63万|-29.41%|54.05万|#|2025-05-15|24.98万|-0.12%|75.49万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522091649a6e816f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522091649a6e816f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","BK4539","APVO"],"gpt_icon":0},{"id":"2537620222","title":"Aptevo Therapeutics Inc.5月20日成交额为13.14万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537620222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537620222?lang=zh_cn&edition=full","pubTime":"2025-05-21 09:16","pubTimestamp":1747790189,"startTime":"0","endTime":"0","summary":"美东时间2025年5月20日，Aptevo Therapeutics Inc.成交额为13.14万美元，成交额较昨日减少36.93%，当日成交量为41.73万股。Aptevo Therapeutics Inc.于2025年5月20日跌0.03%，报0.31美元，该股过去5个交易日跌8.85%，年初至今跌92.81%，过去60日跌90.35%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-20|13.14万|-36.93%|41.73万|#|2025-05-19|20.84万|18.20%|68.69万|#|2025-05-16|17.63万|-29.41%|54.05万|#|2025-05-15|24.98万|-0.12%|75.49万|#|2025-05-14|25.01万|-46.00%|75.71万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521091634a6e6ab1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521091634a6e6ab1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","APVO","BK4539"],"gpt_icon":0},{"id":"2536416956","title":"Aptevo Therapeutics Inc.盘中异动 临近午盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536416956","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536416956?lang=zh_cn&edition=full","pubTime":"2025-05-20 23:40","pubTimestamp":1747755613,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日23时40分，Aptevo Therapeutics Inc.股票出现波动，股价大幅拉升5.13%。截至发稿，该股报0.326美元/股，成交量19.7424万股，换手率3.56%，振幅4.87%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520234014aa2c943e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520234014aa2c943e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APVO","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2536654077","title":"Aptevo Therapeutics Inc.5月19日成交额为20.84万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536654077","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536654077?lang=zh_cn&edition=full","pubTime":"2025-05-20 09:16","pubTimestamp":1747703788,"startTime":"0","endTime":"0","summary":"美东时间2025年5月19日，Aptevo Therapeutics Inc.成交额为20.84万美元，成交额较昨日增加18.20%，当日成交量为68.69万股。Aptevo Therapeutics Inc.于2025年5月19日跌3.13%，报0.31美元，该股过去5个交易日跌8.82%，年初至今跌92.81%，过去60日跌91.07%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-19|20.84万|18.20%|68.69万|#|2025-05-16|17.63万|-29.41%|54.05万|#|2025-05-15|24.98万|-0.12%|75.49万|#|2025-05-14|25.01万|-46.00%|75.71万|#|2025-05-13|46.32万|110.05%|136.67万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520091645a484af6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520091645a484af6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4007","APVO","BK4139"],"gpt_icon":0},{"id":"2536706375","title":"Aptevo Therapeutics Inc.5月16日成交额为17.63万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536706375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536706375?lang=zh_cn&edition=full","pubTime":"2025-05-17 09:16","pubTimestamp":1747444585,"startTime":"0","endTime":"0","summary":"美东时间2025年5月16日，Aptevo Therapeutics Inc.成交额为17.63万美元，成交额较昨日减少29.41%，当日成交量为54.05万股。Aptevo Therapeutics Inc.于2025年5月16日跌3.03%，报0.32美元，该股过去5个交易日跌5.88%，年初至今跌92.58%，过去60日跌90.62%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-16|17.63万|-29.41%|54.05万|#|2025-05-15|24.98万|-0.12%|75.49万|#|2025-05-14|25.01万|-46.00%|75.71万|#|2025-05-13|46.32万|110.05%|136.67万|#|2025-05-12|22.05万|1.21%|65.01万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517091642a48185ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517091642a48185ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APVO","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2517197972","title":"Aptevo Therapeutics Inc.盘中异动 下午盘股价大跌6.68%报2.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517197972","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517197972?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:28","pubTimestamp":1741289314,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时28分，Aptevo Therapeutics Inc.股票出现波动，股价急速跳水6.68%。截至发稿，该股报2.59美元/股，成交量2.5087万股，换手率1.72%，振幅5.25%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.72%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307032834a262d671&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307032834a262d671&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APVO","BK4139","LENZ"],"gpt_icon":0},{"id":"2517983456","title":"Aptevo Therapeutics Inc.盘中异动 下午盘快速下挫5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517983456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517983456?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:57","pubTimestamp":1741118267,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时57分，Aptevo Therapeutics Inc.股票出现异动，股价急速跳水5.88%。截至发稿，该股报2.91美元/股，成交量2.9196万股，换手率2.00%，振幅5.83%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305035747a25f5f02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305035747a25f5f02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APVO","BK4139"],"gpt_icon":0},{"id":"2516655136","title":"Aptevo Therapeutics Inc.盘中异动 临近午盘快速下跌8.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516655136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516655136?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:39","pubTimestamp":1741019963,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日00时39分，Aptevo Therapeutics Inc.股票出现异动，股价急速跳水8.38%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为3922.52%、173.32%、141.87%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、94.90%、70.53%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304003923abe65b30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304003923abe65b30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","APVO"],"gpt_icon":0},{"id":"2514937376","title":"Aptevo Therapeutics Inc.盘中异动 快速拉升5.85%报3.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514937376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514937376?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:41","pubTimestamp":1740757316,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时41分，Aptevo Therapeutics Inc.股票出现异动，股价快速拉升5.85%。截至发稿，该股报3.80美元/股，成交量2.7148万股，换手率1.86%，振幅6.13%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282341579896898f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282341579896898f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APVO","BK4139"],"gpt_icon":0},{"id":"2514738573","title":"Aptevo Therapeutics Inc.盘中异动 股价大涨6.38%报3.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514738573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514738573?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:37","pubTimestamp":1740667074,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时37分，Aptevo Therapeutics Inc.股票出现波动，股价大幅上涨6.38%。截至发稿，该股报3.50美元/股，成交量7331股，换手率0.50%，振幅0.91%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.85%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223754a2567bc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223754a2567bc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APVO","BK4139"],"gpt_icon":0},{"id":"2514856074","title":"Aptevo Therapeutics Inc.盘中异动 早盘快速上涨5.54%报3.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856074?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:34","pubTimestamp":1740580444,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时34分，Aptevo Therapeutics Inc.股票出现异动，股价快速上涨5.54%。截至发稿，该股报3.24美元/股，成交量2465股，换手率0.17%，振幅0.00%。Aptevo Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Aptevo Therapeutics Inc.公司简介：Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223404a254f72d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223404a254f72d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APVO","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aptevotherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0859},{"period":"1month","weight":-0.0142},{"period":"3month","weight":-0.1366},{"period":"6month","weight":-0.7192},{"period":"1year","weight":-0.9931},{"period":"ytd","weight":-0.9839}],"compareEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.0136},{"period":"3month","weight":0.0574},{"period":"6month","weight":0.1423},{"period":"1year","weight":0.1263},{"period":"ytd","weight":0.1677}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aptevo Therapeutics Inc.于2016年2月在特拉华州注册成立。该公司是一家临床阶段的研发生物技术公司，专注于开发用于治疗不同形式癌症的新型免疫疗法候选者。该公司开发了两种多功能平台技术，用于合理设计精准免疫调节药物。该公司的主要临床候选药物APVO436和ALG.APV-527以及临床前候选药物APVO603和APVO711是使用ADAPTIR模块蛋白技术平台开发的。该公司的临床前候选药物APVO442是利用ADAPTIR-FLEX模块蛋白技术平台开发的。该公司的ADAPTIR和ADAPTIR-FLEX平台旨在产生能够增强人体免疫系统对抗癌细胞的单特异性、双特异性和多特异性候选抗体。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":-0.073504},{"month":2,"riseRate":0.222222,"avgChangeRate":-0.064327},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.20989},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.15126},{"month":5,"riseRate":0.555556,"avgChangeRate":-0.026729},{"month":6,"riseRate":0.222222,"avgChangeRate":-0.08688},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.041449},{"month":8,"riseRate":0.111111,"avgChangeRate":-0.166485},{"month":9,"riseRate":0.1,"avgChangeRate":-0.074626},{"month":10,"riseRate":0.3,"avgChangeRate":-0.002789},{"month":11,"riseRate":0.5,"avgChangeRate":0.481281},{"month":12,"riseRate":0.4,"avgChangeRate":-0.098517}],"exchange":"NASDAQ","name":"Aptevo Therapeutics Inc.","nameEN":"Aptevo Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aptevo Therapeutics Inc.(APVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aptevo Therapeutics Inc.(APVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aptevo Therapeutics Inc.,APVO,Aptevo Therapeutics Inc.股票,Aptevo Therapeutics Inc.股票老虎,Aptevo Therapeutics Inc.股票老虎国际,Aptevo Therapeutics Inc.行情,Aptevo Therapeutics Inc.股票行情,Aptevo Therapeutics Inc.股价,Aptevo Therapeutics Inc.股市,Aptevo Therapeutics Inc.股票价格,Aptevo Therapeutics Inc.股票交易,Aptevo Therapeutics Inc.股票购买,Aptevo Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aptevo Therapeutics Inc.(APVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aptevo Therapeutics Inc.(APVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}